Market Access: Finding Balance Amid Radical Change
Globally, the state of pharma could be described as a maelstrom. Healthcare systems are buffeted by the soaring incidence of health threats and an aging population, while costs are escalating, and government and corporate strategies have yet to be harmonized. The challenges lie in securing an agenda to enable the corporate sector and governments to grow together to bring the best outcome for patients.
Key themes covered in this whitepaper include: 

  • Right policy, right problem
  • Legal battles, pricing, and affordability
  • Patient centricity, equity, and meaningful value
  • Collaboration, partnerships, and innovation
Featuring industry contributors: 
  • Ricardo Marek, President Europe & Canada, Takeda Pharmaceuticals
  • Christoph Glaetzer, Chief Global Value and Access, Johnson & Johnson Innovative Medicine
  • Andy Powrie-Smith, Executive Director, Communications & Partnerships, EFPIA
Thanks,
Download your free copy of this industry-leading whitepaper today! 

Fill in your details now for the full whitepaper with insights from experts at Novartis, Novo Nordisk & Alira Health and more! 
Reuters Events will use this information to contact you about relevant content, products, and services. You may unsubscribe at any time. For more information, check out our Privacy Policy: https://www.thomsonreuters.com/en/privacy-statement.html.
Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.